Skip to content

I-DAIR

Induction heating heated debridement antibiotics and implant retention (i-DAIR) safety study - I-DAIR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58440
Enrollment
23
Registered
2025-06-16
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prosthetic Joint Infection implant infection

Interventions

IPD induction heater: IDH of the extra-osseous metal (neck / taper) of the femoral stem and direct heating of the acetabular cup (cemented) or inlay (uncemented). The target temperature is between 60

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18 years or olderScheduled for DAIR for suspected PJI after primary THAThe patient has a primary THA of a brand/type that was tested during the ex vivo studies for having a safe heating profile for i-DAIR*Ability to give informed consent

Exclusion criteria

Exclusion criteria: No informed consentPregnancy or plans for pregnancy during the study period (due to CT migration scans)Medical condition precluding major surgeryPacemakerHemi arthroplastiesDAIR for suspected PJI after revision surgery (regardless of reason)One stage or two stage revision surgery for PJI instead of DAIRConversion of DAIR to one or two stage revision during the same surgical sessionPrimary THA implant is of a different type than tested during ex-vivo studiesPrimary THA implant has not passed the safety profile during ex-vivo studies

Design outcomes

Primary

MeasureTime frame
The main objective of this study is to monitor the bone-implant interface for possible heat induced osteolysis/necrosis after IDH using CT at 3 months. 

Secondary

MeasureTime frame
The secondary objectives are:1)  to monitor the bone-implant interface for possible heat induced osteolysis/necrosis after IDH using CT at 6 months and 1 year follow-up2) to determine the fixation of the femoral stem and acetabular cup after i-DAIR procedure measured using CT radiostereometric analysis (RSA).3) to monitor these patients for any unexpected side effects during the first year post-operatively4) to use the preliminary data on efficacy to guide sample size calculations for the multicentre randomized trial for efficacy.

Countries

Netherlands

Contacts

Public ContactB.G.C.W. Pijls

Leids Universitair Medisch Centrum

b.g.c.w.pijls@lumc.nl0715263606

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026